Search clinical trials for: Rosuvastatin and Ezetimibe

Total 270459 results

Beth Israel Deaconess Medical Center
Massachusetts General Hospital; Dana-Farber Cancer Institute; National Institutes...

Completed

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Breast Cancer

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin

Healthy Subjects

Czechia
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Statins for Acutely Injured Lungs From Sepsis (SAILS)

Sepsis | Acute Lung Injury

United States
University of Sao Paulo
Instituto Dante Pazzanese de Cardiologia

Completed

A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN). (CLEAR-CIN)

Nephropathy

Brazil
Committee of Cardio-Cerebral-Vascular Diseases...
AstraZeneca

Unknown

LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients

Acute Coronary Syndrome

China
Universidad Autonoma de San Luis Potosí
AstraZeneca; Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury

Head Injury

Mexico
AstraZeneca

Completed

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

Renal Failure

Sweden, Bulgaria, Czech Republic, France, Poland, United Kingdom, Germany, Hungary, Finland, Netherlands, Norway, Canada, Mexico, Australia, Austria, Belgium, Denmark, Greece, Italy, Iceland, Brazil, Switzerland, Ireland, Korea, Republic... and more
Radboud University Medical Center

Completed

Rosuvastatin and Ischemia Reperfusion

Ischemia

Netherlands
AstraZeneca

Completed

DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

Hypercholesterolemia

China, Taiwan, Malaysia, Hong Kong, Korea, Republic of, Thailand
Universidade Federal do Rio Grande do Norte
University of Sao Paulo

Completed

Zinc and Selenium Supplementation in Atherosclerosis

Dietary Zinc Deficiency | Dietary Selenium Deficiency

Brazil
Centre de Recherche de l'Institut Universitaire...

Completed

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects (SPICE)

Coronary Artery Disease

Canada
Samsung Medical Center

Not yet recruiting

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium (DECISION-CAL)

Metabolic Syndrome | Dyslipidemias | Coronary Artery Calcification
Organon and Co

Completed

EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)

Atherosclerosis
Texas A&M University
Nutrabolt

Completed

Safety of Different Forms of Creatine (NB9)

Nutritional Supplements
Pfizer

Terminated

A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin (PROSE)

Pulmonary Arterial Hypertension

Belgium, Germany, France
Esperion Therapeutics, Inc.

Recruiting

Bempedoic Acid Pregnancy Surveillance Program

Pregnancy | Hyperlipidemias

United States
Amgen

Completed

Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 (MENDEL-2)

Hyperlipidemia

United States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
Organon and Co

Completed

A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

Hypercholerolemia
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Statin and Atheroma Vulnerability Evaluation (STABLE)

Coronary Artery Disease

Korea, Republic of
Celltrion

Completed

A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

Health, Subjective

Korea, Republic of
Organon and Co
Merck Sharp & Dohme LLC

Completed

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

Hypercholesterolemia | Hyperlipidemia
Stanford University

Recruiting

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

Inflammatory Bowel Diseases | Primary Sclerosing Cholangitis

United States
AstraZeneca
Parexel

Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

Dyslipidemia

United States, United Kingdom
Bayer

Completed

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Germany
Sony Tuteja

Active, not recruiting

Investigation of the Gut Microbiome and Statin Response (INGEST)

Healthy Volunteers

United States
CHEOL WHAN LEE, M.D., Ph.D
CardioVascular Research Foundation, Korea

Terminated

EARly Prevention of aTHeroma Progression (EARTH)

Coronary Arteriosclerosis

Korea, Republic of
Centro Cardiopatici Toscani

Completed

Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2) (PRATO-ACS-2)

Acute Coronary Syndrome

Italy
Xiao-dong Zhuang
Sun Yat-sen University

Unknown

Rosuvastatin Effect on Telomere-telomerase System in ACS

Telomere Length, Mean Leukocyte | Telomere Shortening | 22q Telomere Deletion Syndrome
Soroka University Medical Center

Unknown

Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery

Severe Pre-eclampsia
University of Oxford
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaborators

Completed

Statin Therapy In Cardiac Surgery (STICS)

Atrial Fibrillation | Myocardium; Injury

China
Harbin Medical University

Completed

Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)

Coronary Artery Disease | Hyperlipidemia

China
AstraZeneca

Completed

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Dyslipidemia, Renal Insufficiency

United States
Beijing Anzhen Hospital

Unknown

Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI (ARISE)

Focus of Study

China
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) (ENHANCE)

Atherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
Amgen

Completed

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 (GAUSS-4)

Hypercholesterolemia

Japan
Osaka University
Kowa Company, Ltd.

Terminated

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease (PIT-ROAD)

Alzheimer Disease | Hypercholesterolemia

Japan
Yonsei University

Recruiting

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Dyslipidemias | Venous Thromboembolism

Korea, Republic of
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

Healthy Subjects

Czechia
Beijing Friendship Hospital

Unknown

Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients

Acute Coronary Syndrome

China
Yonsei University

Completed

Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study

A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.

Korea, Republic of
University of Oslo School of Pharmacy
Oslo University Hospital

Completed

The Rosuvastatin In TrAnsplant Recipients Study (RITA)

Hypercholesterolemia | Disorder Related to Renal Transplantation

Norway
Chinese University of Hong Kong

Completed

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

Rheumatoid Arthritis

China
AstraZeneca

Completed

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

Metabolic Syndrome | Dyslipidemia

Australia
University of Roma La Sapienza

Completed

Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) (ROMA)

Periprocedural Myocardial Necrosis

Italy
AstraZeneca

Completed

OLE Study to Evaluate Safety / Efficacy of ZD4522

Hypercholesterolaemia
Bader, Ted, M.D.

Completed

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Hepatitis C

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Colorectal Cancer | Precancerous Condition

United States, Canada
Tanta University

Completed

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Breast Cancer | Chemotherapy-induced Cardiotoxicity

Egypt
University Hospital, Akershus
Oslo University Hospital; AstraZeneca

Withdrawn

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy (DECAMERONE)

Depression

Norway
Ottawa Heart Institute Research Corporation
Ontario HIV Treatment Network

Completed

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Human Immunodeficiency Virus (HIV) | Cardiovascular Disease (CVD)

Canada

Search clinical trials for: Rosuvastatin and Ezetimibe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations